STAT1d
Small vaccine maker names Operation Warp Speed leader as chairman, raises $110 million
Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...
Fierce Biotech1d
Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead board
In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...
Editorial: A pandemic’s lessons
This week marks a somber anniversary: five years since New York shut down as a deadly virus was ravaging the state, the ...
Is the U.S. prepared for another pandemic?
Yahoo News spoke with Dr. Ashish Jha, former White House COVID-19 response coordinator under the Biden administration, who ...
America Can’t Be Great if America Is Stupid
Trump’s attack on higher education and scientific research undermines some of our most competitive advantages.
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...
Daily Camera4dOpinion
Editorial: What have we learned in 5 years with COVID?
Five years on from the outbreak of COVID-19, there are lessons to be learned about the importance of preparation and the need ...